<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05614609</url>
  </required_header>
  <id_info>
    <org_study_id>Sykehuset Østfold</org_study_id>
    <nct_id>NCT05614609</nct_id>
  </id_info>
  <brief_title>Discomfort in Upper Airways Due to intubation-a Randomized Controlled Trial</brief_title>
  <official_title>Discomfort in Upper Airways Due to intubation-a Randomized Controlled Trial in a Norwegian Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ostfold University College</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ostfold University College</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Few studies have compared different methods for optimalizing intubation conditions in general&#xD;
      anesthesia. This randomized controlled trial will compare two different methods for&#xD;
      intubation in general anesthesia in gastro- or gynecological procedures.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In general anesthesia, it is neccessary to secure the airways with an endotracheal tube.&#xD;
      There is no international consensus on how intubation is most efficiently conducted. A&#xD;
      cochrane review compared using muscular relaxing medication versus not using blocks for&#xD;
      intubation. Primary outcomes were intubation conditions and discomfort in upper airways. The&#xD;
      authors concluded that research is limited, and that further research is needed. No studies&#xD;
      have compared local anesthetic spray on the glottis and muscular relaxing medication in&#xD;
      intubation, focusing on discomfort in upper airways. The null-hypothesis of this study is&#xD;
      that there is no difference in upper airway discomfort when using local anesthetic spray or&#xD;
      muscular relaxing medication. The study will have a randomized controlled design, randomizing&#xD;
      patients undergoing gastro- or gynecological procedures in general anesthesia to receiving&#xD;
      either rocuronium (muscle relaxing medication) intravenous, or lidocain spray on the glottis&#xD;
      before intubation. The primary outcome is postoperativ hoarseness two hours after intubation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2023</start_date>
  <completion_date type="Anticipated">January 31, 2024</completion_date>
  <primary_completion_date type="Anticipated">November 15, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Block randomization through randomization.com. Proprotion of hoarseness grade-2-or-3 = 30 % in spray and 10 % in rocuronium.&#xD;
59 patients in each arm.&#xD;
&quot;sig p &lt;= ,05&quot;, H0 = 0 + 1,96*√[30(100-30)n + 10(100-10)/n] Gitt &quot;power &gt;= ,80&quot; , HAlt = (30-10) - 0,84*√[30(100-30/n) + 10(100- 10/n)]</intervention_model_description>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>A study nurse will prepare sealed envelopes with the study-arm specified inside. Patients fullfilling the inclusion criteria will be invited to participate. Patients will be blinded for study arm. Intubation will be performed by trained intubators. However, due to the medications possible risk for rest-curarisation, the anesthesia personnel will possibly be able to detect intervention. However, care personnel collecting data will not know which study arm the patient belongs to.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Degree of hoarseness 2 hours after extubation</measure>
    <time_frame>2 hours</time_frame>
    <description>Scored on a scale : 0=no, 1= self reported hoarseness, 2=observed hoarsness by care personnel, 3=aphonia</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intubation conditions</measure>
    <time_frame>Before intubation</time_frame>
    <description>Cormack &amp; Lehane four degrees</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of intubation attempts</measure>
    <time_frame>At intubation</time_frame>
    <description>Number</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients needing extra equipment for intubating</measure>
    <time_frame>At intubation</time_frame>
    <description>bourgie, c-mac, other</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients who cough when spraying</measure>
    <time_frame>At intubation</time_frame>
    <description>yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with normal anatomy in upper airways</measure>
    <time_frame>At intubation</time_frame>
    <description>yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure changes during intubation</measure>
    <time_frame>at intubation</time_frame>
    <description>Blood pressure before and 2 minutes after intubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart rate changes during intubation</measure>
    <time_frame>at intubation</time_frame>
    <description>Heart rate before and 2 minutes after intubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients who cough on tube at extubation</measure>
    <time_frame>At extubation</time_frame>
    <description>yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients with blood on tube after extubation</measure>
    <time_frame>At extubation</time_frame>
    <description>yes/no</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Degree of hoarsness 24 and 48 hours after extubation</measure>
    <time_frame>2-48 hours</time_frame>
    <description>Scored on a scale : 0=no, 1= self reported hoarseness, 2=observed hoarsness by care personnel, 3=aphonia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Proportion of patients reporting different degrees of sore throat at 2, 24 and 48 hours after extubation</measure>
    <time_frame>2-48 hours</time_frame>
    <description>0=no, 1=mild, 2=moderate, constant pain when swallowing, 3=severe pain needing analgesia</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Postoperative Complications</condition>
  <condition>Intubation; Difficult or Failed</condition>
  <condition>Intubation Complication</condition>
  <arm_group>
    <arm_group_label>Lidocaine spray on the glottis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Lidocaine 20 mgl/ml- 4,4 ml will be sprayed on the glottis. Ventilation for 90 sek, intubation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Muscle relaxing medication</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Rocuronium 0,6 mg/kg administered intravenous. Ventilation for 2.5 minutes (150seconds), intubation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine topical</intervention_name>
    <description>Comparing lidocaine spray and muscle relaxing medication</description>
    <arm_group_label>Lidocaine spray on the glottis</arm_group_label>
    <arm_group_label>Muscle relaxing medication</arm_group_label>
    <other_name>Rocurinoum 0.6 mg/kg intravenous</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA (American Association of Anesthesiologists Classification system for physical&#xD;
             status) I-III&#xD;
&#xD;
          -  Understand and can express themselves in Norwegian&#xD;
&#xD;
          -  Able to give informed consent to participate&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cave lidocain and/or muscle relaxing medication&#xD;
&#xD;
          -  BMI above 40&#xD;
&#xD;
          -  Anticipated difficult intubation&#xD;
&#xD;
          -  Need for ventricular tube&#xD;
&#xD;
          -  Pathology or malformations in upper airways&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Ann-Chatrin Linqvist Leonardsen</name>
      <address>
        <city>Kråkerøy</city>
        <state>Østfold</state>
        <zip>1679</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ann -Chatrin L Leonardsen, PhD</last_name>
      <phone>+4741668797</phone>
      <email>ann.c.leonardsen@hiof.no</email>
    </contact>
    <contact_backup>
      <last_name>Waleed Ghanima, PhD, Professor</last_name>
      <email>waleed.ghanima@so-hf.no</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>October 31, 2022</study_first_submitted>
  <study_first_submitted_qc>November 5, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2022</study_first_posted>
  <last_update_submitted>March 21, 2023</last_update_submitted>
  <last_update_submitted_qc>March 21, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ostfold Hospital Trust</investigator_affiliation>
    <investigator_full_name>Ann-Chatrin Leonardsen</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

